Copyright Reports & Markets. All rights reserved.

Global Diabetes Care Devices & Drugs Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Diabetes Care Devices & Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Diabetes Care Devices & Drugs Market Size Growth Rate by Product
      • 1.4.2 Insulin
      • 1.4.3 Rapid Acting Insulin
      • 1.4.4 Short Acting Insulin
      • 1.4.5 Diabetes Care Devices
      • 1.4.6 Diabetes Monitoring Devices
      • 1.4.7 Other
    • 1.5 Market by End User
      • 1.5.1 Global Diabetes Care Devices & Drugs Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Household
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Diabetes Care Devices & Drugs Market Size
      • 2.1.1 Global Diabetes Care Devices & Drugs Revenue 2014-2025
      • 2.1.2 Global Diabetes Care Devices & Drugs Sales 2014-2025
    • 2.2 Diabetes Care Devices & Drugs Growth Rate by Regions
      • 2.2.1 Global Diabetes Care Devices & Drugs Sales by Regions
      • 2.2.2 Global Diabetes Care Devices & Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Diabetes Care Devices & Drugs Sales by Manufacturers
      • 3.1.1 Diabetes Care Devices & Drugs Sales by Manufacturers
      • 3.1.2 Diabetes Care Devices & Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Diabetes Care Devices & Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Diabetes Care Devices & Drugs Revenue by Manufacturers
      • 3.2.1 Diabetes Care Devices & Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Diabetes Care Devices & Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Diabetes Care Devices & Drugs Price by Manufacturers
    • 3.4 Diabetes Care Devices & Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Diabetes Care Devices & Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Diabetes Care Devices & Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Diabetes Care Devices & Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Diabetes Care Devices & Drugs Sales by Product
    • 4.2 Global Diabetes Care Devices & Drugs Revenue by Product
    • 4.3 Diabetes Care Devices & Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Diabetes Care Devices & Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Diabetes Care Devices & Drugs by Countries
      • 6.1.1 North America Diabetes Care Devices & Drugs Sales by Countries
      • 6.1.2 North America Diabetes Care Devices & Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Diabetes Care Devices & Drugs by Product
    • 6.3 North America Diabetes Care Devices & Drugs by End User

    7 Europe

    • 7.1 Europe Diabetes Care Devices & Drugs by Countries
      • 7.1.1 Europe Diabetes Care Devices & Drugs Sales by Countries
      • 7.1.2 Europe Diabetes Care Devices & Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Diabetes Care Devices & Drugs by Product
    • 7.3 Europe Diabetes Care Devices & Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Diabetes Care Devices & Drugs by Countries
      • 8.1.1 Asia Pacific Diabetes Care Devices & Drugs Sales by Countries
      • 8.1.2 Asia Pacific Diabetes Care Devices & Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Diabetes Care Devices & Drugs by Product
    • 8.3 Asia Pacific Diabetes Care Devices & Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Diabetes Care Devices & Drugs by Countries
      • 9.1.1 Central & South America Diabetes Care Devices & Drugs Sales by Countries
      • 9.1.2 Central & South America Diabetes Care Devices & Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Diabetes Care Devices & Drugs by Product
    • 9.3 Central & South America Diabetes Care Devices & Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Diabetes Care Devices & Drugs by Countries
      • 10.1.1 Middle East and Africa Diabetes Care Devices & Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Diabetes Care Devices & Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Diabetes Care Devices & Drugs by Product
    • 10.3 Middle East and Africa Diabetes Care Devices & Drugs by End User

    11 Company Profiles

    • 11.1 Abbott Laboratories
      • 11.1.1 Abbott Laboratories Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Laboratories Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Laboratories Diabetes Care Devices & Drugs Products Offered
      • 11.1.5 Abbott Laboratories Recent Development
    • 11.2 Ascensia Diabetes Care Holdings
      • 11.2.1 Ascensia Diabetes Care Holdings Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Ascensia Diabetes Care Holdings Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Ascensia Diabetes Care Holdings Diabetes Care Devices & Drugs Products Offered
      • 11.2.5 Ascensia Diabetes Care Holdings Recent Development
    • 11.3 AstraZeneca
      • 11.3.1 AstraZeneca Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 AstraZeneca Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 AstraZeneca Diabetes Care Devices & Drugs Products Offered
      • 11.3.5 AstraZeneca Recent Development
    • 11.4 Boehringer Ingelheim GmbH
      • 11.4.1 Boehringer Ingelheim GmbH Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Boehringer Ingelheim GmbH Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Boehringer Ingelheim GmbH Diabetes Care Devices & Drugs Products Offered
      • 11.4.5 Boehringer Ingelheim GmbH Recent Development
    • 11.5 Eli Lilly And
      • 11.5.1 Eli Lilly And Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Eli Lilly And Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Eli Lilly And Diabetes Care Devices & Drugs Products Offered
      • 11.5.5 Eli Lilly And Recent Development
    • 11.6 Hoffmann-La Roche
      • 11.6.1 Hoffmann-La Roche Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Hoffmann-La Roche Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Hoffmann-La Roche Diabetes Care Devices & Drugs Products Offered
      • 11.6.5 Hoffmann-La Roche Recent Development
    • 11.7 Johnson & Johnson
      • 11.7.1 Johnson & Johnson Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Johnson & Johnson Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Johnson & Johnson Diabetes Care Devices & Drugs Products Offered
      • 11.7.5 Johnson & Johnson Recent Development
    • 11.8 Medtronic PLC
      • 11.8.1 Medtronic PLC Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Medtronic PLC Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Medtronic PLC Diabetes Care Devices & Drugs Products Offered
      • 11.8.5 Medtronic PLC Recent Development
    • 11.9 Novartis
      • 11.9.1 Novartis Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Novartis Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Novartis Diabetes Care Devices & Drugs Products Offered
      • 11.9.5 Novartis Recent Development
    • 11.10 Novo Nordisk A/S
      • 11.10.1 Novo Nordisk A/S Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Novo Nordisk A/S Diabetes Care Devices & Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Novo Nordisk A/S Diabetes Care Devices & Drugs Products Offered
      • 11.10.5 Novo Nordisk A/S Recent Development
    • 11.11 Ypsomed
    • 11.12 Terumo

    12 Future Forecast

    • 12.1 Diabetes Care Devices & Drugs Market Forecast by Regions
      • 12.1.1 Global Diabetes Care Devices & Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Diabetes Care Devices & Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Diabetes Care Devices & Drugs Market Forecast by Product
      • 12.2.1 Global Diabetes Care Devices & Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Diabetes Care Devices & Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Diabetes Care Devices & Drugs Market Forecast by End User
    • 12.4 North America Diabetes Care Devices & Drugs Forecast
    • 12.5 Europe Diabetes Care Devices & Drugs Forecast
    • 12.6 Asia Pacific Diabetes Care Devices & Drugs Forecast
    • 12.7 Central & South America Diabetes Care Devices & Drugs Forecast
    • 12.8 Middle East and Africa Diabetes Care Devices & Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Diabetes Care Devices & Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs.
      The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet.
      The global Diabetes Care Devices & Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetes Care Devices & Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Diabetes Care Devices & Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetes Care Devices & Drugs in these regions.
      This research report categorizes the global Diabetes Care Devices & Drugs market by top players/brands, region, type and end user. This report also studies the global Diabetes Care Devices & Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott Laboratories
      Ascensia Diabetes Care Holdings
      AstraZeneca
      Boehringer Ingelheim GmbH
      Eli Lilly And
      Hoffmann-La Roche
      Johnson & Johnson
      Medtronic PLC
      Novartis
      Novo Nordisk A/S
      Ypsomed
      Terumo

      Market size by Product
      Insulin
      Rapid Acting Insulin
      Short Acting Insulin
      Diabetes Care Devices
      Diabetes Monitoring Devices
      Other
      Market size by End User
      Hospital
      Household

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Diabetes Care Devices & Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Diabetes Care Devices & Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Diabetes Care Devices & Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Diabetes Care Devices & Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Diabetes Care Devices & Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetes Care Devices & Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now